CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
research
Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study
Authors
C Dobson-Stone
M Fraser
+5 more
L Lonie
A P Monaco
D E Porter
J R Porter
Hamish Simpson
Publication date
1 January 2004
Publisher
'British Editorial Society of Bone & Joint Surgery'
Doi
Cite
Abstract
We performed a prospective genotype-phenotype study using molecular screening and clinical assessment to compare the severity of disease and the risk of sarcoma in 172 individuals (78 families) with hereditary multiple exostoses. We calculated the severity of disease including stature, number of exostoses, number of surgical procedures that were necessary, deformity and functional parameters and used molecular techniques to identify the genetic mutations in affected individuals. Each arm of the genotype-phenotype study was blind to the outcome of the other. Mutations EXT1 and EXT2 were almost equally common, and were identified in 83% of individuals. Non-parametric statistical tests were used. There was a wide variation in the severity of disease. Children under ten years of age had fewer exostoses, consistent with the known age-related penetrance of this condition. The severity of the disease did not differ significantly with gender and was very variable within any given family. The sites of mutation affected the severity of disease with patients with EXT1 mutations having a significantly worse condition than those with EXT2 mutations in three of five parameters of severity (stature, deformity and functional parameters). A single sarcoma developed in an EXT2 mutation carrier, compared with seven in EXT1 mutation carriers. There was no evidence that sarcomas arose more commonly in families in whom the disease was more severe. The sarcoma risk in EXT1 carriers is similar to the risk of breast cancer in an older population subjected to breast-screening, suggesting that a role for regular screening in patients with hereditary multiple exostoses is justifiable. ©2004 British Editorial Society of Bone and Joint Surgery
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Oxford University Research Archive (ORA)
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 18/04/2020
Supporting member
Oxford University Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ora.ox.ac.uk:uuid:bd9f2c55...
Last time updated on 30/09/2015
ORA - Oxford University Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ora.ox.ac.uk:uuid:bd9f2c55...
Last time updated on 13/04/2022
Supporting member
Oxford University Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ora.ox.ac.uk:uuid:15cfd13d...
Last time updated on 30/09/2015
Oxford University Research Archive (ORA)
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 18/04/2020
Edinburgh Research Explorer
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:pure.ed.ac.uk:publications...
Last time updated on 08/02/2015